Adooq Bioscience
ENOblock (AP-III-a4) is a novel small molecule which is the first, nonsubstrate analogue that directly binds to enolase and inhibits its activity (IC50=0.576 uM); inhibit cancer cell metastasis in vivo.
More Information
Supplier Page
Adooq Bioscience
Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment
More Information
Supplier Page
Adooq Bioscience
Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment
More Information
Supplier Page
Adooq Bioscience
Cabazitaxel is a semi-synthetic derivative of a natural taxoid. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment
More Information
Supplier Page
Adooq Bioscience
Adooq Bioscience
Adooq Bioscience
Adooq Bioscience
Adooq Bioscience
Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information
Supplier Page
Adooq Bioscience
Articaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information
Supplier Page